Cargando…
Gene augmentation prevents retinal degeneration in a CRISPR/Cas9-based mouse model of PRPF31 retinitis pigmentosa
Mutations in PRPF31 cause autosomal dominant retinitis pigmentosa, an untreatable form of blindness. Gene therapy is a promising treatment for PRPF31-retinitis pigmentosa, however, there are currently no suitable animal models in which to develop AAV-mediated gene augmentation. Here we establish Prp...
Autores principales: | Xi, Zhouhuan, Vats, Abhishek, Sahel, José-Alain, Chen, Yuanyuan, Byrne, Leah C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744804/ https://www.ncbi.nlm.nih.gov/pubmed/36509783 http://dx.doi.org/10.1038/s41467-022-35361-8 |
Ejemplares similares
-
Modeling PRPF31 retinitis pigmentosa using retinal pigment epithelium and organoids combined with gene augmentation rescue
por: Rodrigues, Amélie, et al.
Publicado: (2022) -
CNOT3 Is a Modifier of PRPF31 Mutations in Retinitis Pigmentosa with Incomplete Penetrance
por: Venturini, Giulia, et al.
Publicado: (2012) -
Novel PRPF31 mutations associated with Chinese autosomal dominant retinitis pigmentosa patients
por: Xu, Fei, et al.
Publicado: (2012) -
Mutation spectrum of PRPF31, genotype-phenotype correlation in retinitis pigmentosa, and opportunities for therapy
por: Wheway, Gabrielle, et al.
Publicado: (2020) -
A Novel PRPF31 Mutation in a Large Chinese Family with Autosomal Dominant Retinitis Pigmentosa and Macular Degeneration
por: Lu, Fang, et al.
Publicado: (2013)